Cancer Researchers on the Rise: Amin Sobh, Ph.D.
Amin Sobh, Ph.D., studies multiple myeloma, the second most common blood cancer.
Amin Sobh, Ph.D., studies multiple myeloma, the second most common blood cancer.
The article spotlights Amin Sobh's research advancing new therapeutic targets in multiple myeloma, with the help of AACR funding.
Researchers identified a novel mechanism in the epigenome that could pave the way to develop new therapies for multiple myeloma.
UF Health Cancer Center researchers discovered a role of a protein in regulating genes that affect the immune system response to multiple myeloma.